{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:41:27Z","timestamp":1784151687826,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12028-013-9882-6","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T15:38:23Z","timestamp":1375112303000},"page":"484-488","source":"Crossref","is-referenced-by-count":38,"title":["Intravenous Lacosamide in Refractory Seizure Clusters and Status Epilepticus: Comparison of 200 and 400\u00a0mg Loading Doses"],"prefix":"10.1007","volume":"20","author":[{"given":"Benjamin","family":"Legros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Depondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levy-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Ligot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mavroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Naeije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gaspard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,30]]},"reference":[{"key":"9882_CR1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348\u201355.","journal-title":"Eur J Neurol"},{"issue":"1","key":"9882_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323.","journal-title":"Neurocrit Care"},{"key":"9882_CR3","first-page":"1","volume":"8","author":"SE Hocker","year":"2012","unstructured":"Hocker SE, Britton JW, Mandrekar JN, Wijdicks EFM, Rabinstein AA. Predictors of outcome in refractory status epilepticus. Arch Neurol. 2012;8:1\u20136.","journal-title":"Arch Neurol"},{"issue":"9","key":"9882_CR4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1097\/CCM.0b013e3182591ff1","volume":"40","author":"RG Kowalski","year":"2012","unstructured":"Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40(9):2677\u201384.","journal-title":"Crit Care Med"},{"issue":"7","key":"9882_CR5","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","volume":"52","author":"V Alvarez","year":"2011","unstructured":"Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52(7):1292\u20136.","journal-title":"Epilepsia"},{"issue":"5","key":"9882_CR6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.seizure.2011.01.017","volume":"20","author":"JM Albers","year":"2011","unstructured":"Albers JM, Moddel G, Dittrich R, et al. Intravenous lacosamide\u2014an effective add-on treatment of refractory status epilepticus. Seizure. 2011;20(5):428\u201330.","journal-title":"Seizure"},{"issue":"7","key":"9882_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.seizure.2011.03.010","volume":"20","author":"K Rantsch","year":"2011","unstructured":"Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure. 2011;20(7):529\u201332.","journal-title":"Seizure"},{"issue":"1","key":"9882_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yebeh.2010.10.012","volume":"20","author":"KA Parkerson","year":"2011","unstructured":"Parkerson KA, Reinsberger C, Chou SH, Dworetzky BA, Lee JW. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav. 2011;20(1):48\u201351.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"9882_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.2010.01430.x","volume":"123","author":"MZ Koubeissi","year":"2011","unstructured":"Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand. 2011;123(2):142\u20136.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"9882_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","volume":"123","author":"C Kellinghaus","year":"2011","unstructured":"Kellinghaus C, Berning S, Immisch I, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand. 2011;123(2):137\u201341.","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"9882_CR11","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1111\/j.1528-1167.2011.03204.x","volume":"52","author":"J Hofler","year":"2011","unstructured":"Hofler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia. 2011;52(10):e148\u201352.","journal-title":"Epilepsia"},{"issue":"3","key":"9882_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12028-010-9501-8","volume":"14","author":"H Goodwin","year":"2011","unstructured":"Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ III. The use of lacosamide in refractory status epilepticus. Neurocrit Care. 2011;14(3):348\u201353.","journal-title":"Neurocrit Care"},{"issue":"4","key":"9882_CR13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1528-1167.2012.03419.x","volume":"53","author":"V Jain","year":"2012","unstructured":"Jain V, Harvey AS. Treatment of refractory tonic status epilepticus with intravenous lacosamide. Epilepsia. 2012;53(4):761\u20132.","journal-title":"Epilepsia"},{"issue":"3","key":"9882_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2011.12.008","volume":"21","author":"L Mnatsakanyan","year":"2012","unstructured":"Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. Intravenous lacosamide in refractory nonconvulsive status epilepticus. Seizure. 2012;21(3):198\u2013201.","journal-title":"Seizure"},{"issue":"2","key":"9882_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12028-011-9662-0","volume":"16","author":"S Cherry","year":"2012","unstructured":"Cherry S, Judd L, Muniz JC, Elzawahry H, LaRoche S. Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care. 2012;16(2):294\u20138.","journal-title":"Neurocrit Care"},{"issue":"3","key":"9882_CR16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/epi.12058","volume":"54","author":"J H\u00f6fler","year":"2013","unstructured":"H\u00f6fler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;54(3):393\u2013404.","journal-title":"Epilepsia"},{"issue":"1","key":"9882_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1212\/WNL.47.1.83","volume":"47","author":"GB Young","year":"1996","unstructured":"Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47(1):83\u20139.","journal-title":"Neurology"},{"issue":"3","key":"9882_CR18","first-page":"2","volume":"20","author":"V Belcastro","year":"2011","unstructured":"Belcastro V, Arnaboldi M, Taborelli A, Prontera P. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine. YEBEH. 2011;20(3):2.","journal-title":"YEBEH"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-013-9882-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-013-9882-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-013-9882-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:14:37Z","timestamp":1559441677000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-013-9882-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,30]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9882"],"URL":"https:\/\/doi.org\/10.1007\/s12028-013-9882-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,30]]}}}